CHICAGO, IL -- February 26, 2007 -- PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today introduced LABWORKS™ LIMS 6.0, a scaleable Laboratory Information Management System (LIMS) that will provide customers with improved flexibility, choice and control of their LIMS. This solution delivers a common architecture for both Web and console/client applications and will debut at the PerkinElmer Booth, 843, at PITTCON® 2007.

“The LABWORKS LIMS new release is in response to customers’ needs for a tailored yet simpler and easier-to-use data management and control system that works within their company’s laboratory operations and enterprise,” said Robert Hudson, global director of sales and service for Enterprise Software Solutions. “We’ve leveraged our deep history and expertise in delivering effective LIMS solutions to provide customers with long-term data management solutions that can meet their needs for stability and control while at the same time providing flexibility to adapt to their ever-changing business environments.”

A key feature of the improved workflow management system is WorkflowArchitect™, a new graphical workflow editor designed to allow the user to easily tailor and test changes to the default LABWORKS workflow. Additional features include the updated LABWORKS Desktop providing an integrated real-time Desktop Messenger system to facilitate real-time communication and system notifications that are important for effective handling of routine and exceptional situations; an integrated Electronic Signature to assist labs in securing faster compliance and approvals; a ClickOnce Subscriber model that improves uniformity and lowers the cost to maintain the system by providing both functionality and ease-of-deployment; and new services for data integration enabling easier sharing of LABWORKS information within the laboratory and the larger enterprise.

Hudson noted that LIMS are most effective when the laboratory personnel who provide the content can recognize their own processes and terminology in the system. “While even the best-designed workflows will have points requiring human intervention, the integration of the WorkflowArchitect with both the new Desktop Messenger and Electronic Signature exemplify our understanding of and response to laboratory needs,” Hudson added.

LABWORKS LIMS is a particularly valuable tool for applications in the chemical, petrochemical, water and wastewater, agriculture, food and beverage and process control arenas, helping customers automate instrumentation, integrate laboratory processes and provide sample information management and quality control from scheduling through analysis and reporting.

For more information about LABWORKS LIMS and its WorkflowArchitect, visit www.perkinelmer.com/labworks.

Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as “believes,” “intends,” “anticipates,” “plans,” “expects,” “projects,” “forecasts,” “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements.  Such statements are based on management’s current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct.  A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements.  These factors include, without limitation: (1) our failure to introduce new products in a timely manner; (2) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (3) our failure to protect adequately our intellectual property; (4) the loss of any of our licenses or licensed rights; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) our ability to produce an adequate quantity of products to meet our customers’ demands; (8) our failure to maintain compliance with applicable government regulations; (9) regulatory changes; (10) economic, political and other risks associated with foreign operations; (11) our ability to retain key personnel; (12) restrictions in our credit agreement; (13) our ability to realize the full value of our intangible assets; and (14) other factors which we describe under the caption “Risk Factors” in our most recent annual report on Form 10-K and in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Other Information
Health Sciences end markets include genetic screening, environmental, service, biopharma, and medical imaging.  Photonics markets include sensors and specialty lighting.